Loading…
Lobbying Spend
—
Filings
37
Firms Hired
1
Active Period
2018–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Orange Book Transparency Act of 2020
2020 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2020 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1520
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 2113
Elijah E. Cummings Lower Drug Costs Now Act
2020 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R 3
Prescription Drug Pricing Reduction Act of 2019
2020 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: S. 2543
Orange Book Transparency Act of 2020
2020 · third_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2020 · third_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1520
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 2113
Elijah E. Cummings Lower Drug Costs Now Act
2020 · third_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R 3
Prescription Drug Pricing Reduction Act of 2019
2020 · third_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: S. 2543
Orange Book Transparency Act of 2020
2020 · second_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2020 · second_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1520
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 2113
Elijah E. Cummings Lower Drug Costs Now Act
2020 · second_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R 3
Prescription Drug Pricing Reduction Act of 2019
2020 · second_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: S. 2543
Orange Book Transparency Act of 2020
2020 · first_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2020 · first_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1520
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 2113
Elijah E. Cummings Lower Drug Costs Now Act
2020 · first_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R 3
Prescription Drug Pricing Reduction Act of 2019
2020 · first_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Client expense: — · Firm income: $25,000
Matched citations: S. 2543
Orange Book Transparency Act of 2020
2019 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2019 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1520
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 2113
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R 3
Orange Book Transparency Act of 2020
2019 · fourth_quarter · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Client expense: — · Firm income: $25,000
Matched citations: H.R. 1503
Source: Senate LDA